CNS Pharmaceuticals Inc. (NASDAQ: CNSP)
$1.12
-0.0600 ( -5.08% ) 419.9K
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
Market Data
Open
$1.12
Previous close
$1.18
Volume
419.9K
Market cap
$3.18M
Day range
$1.08 - $1.20
52 week range
$1.00 - $137.50
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Sep 25, 2023 |
4 | Insider transactions | 1 | Sep 25, 2023 |
8-k | 8K-related | 13 | Sep 19, 2023 |
4 | Insider transactions | 1 | Aug 23, 2023 |
8-k | 8K-related | 12 | Aug 18, 2023 |
4 | Insider transactions | 1 | Aug 16, 2023 |
8-k | 8K-related | 13 | Aug 15, 2023 |
def | Proxies and info statements | 1 | Aug 14, 2023 |
8-k | 8K-related | 14 | Aug 14, 2023 |
10-q | Quarterly Reports | 39 | Aug 14, 2023 |